Crossmark

Junctional adhesion molecular 3 (JAM3) is a novel tumor suppressor and improves the prognosis in breast cancer brain metastases via the TGF-β/Smad signal pathway

Crossref DOI link: https://doi.org/10.1007/s11060-024-04797-x

Published Online: 2024-09-25

Published Print: 2024-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhu, Kaitao

Li, Shiwei

Yao, Hongru

Hei, Jilong

Jiang, WenGuo

Martin, Tracey

Zhang, Shanyi
Funding

Funding for this research was provided by:

Natural Science Foundation of Guangdong Province (2022A1515012393)

The General Program of Medical Scientific Research Foundation of Guangdong (A2016072)

The Qihang Scientific General Project of Sun Yat-Sen Memorial Hospital (YXQH201803)

the Key Research and Development Plan Project of Guangzhou (2023B03J0079)

Cancer Research Wales(WGJ2013), the CardiffChina Medical Scholar-ship (CCMRC2017)
License Information

Text and Data Mining valid from 2024-09-25

Version of Record valid from 2024-09-25
More Information

Article History

Received: 12 July 2024

Accepted: 7 August 2024

First Online: 25 September 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below